Phase 1/2a study of AZD5305, a novel poly(adenosine diphosphate ribose) polymerase (PARP) 1-selective inhibitor in combination with new hormonal agents (NHAs) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results